Spero Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. 

CEO
Ankit A. Mahadevia
CEOAnkit A. Mahadevia
Employees
146
Employees146
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
146
Employees146

SPRO Key Statistics

Market cap
73.29M
Market cap73.29M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
31.39M
Average volume31.39M
High today
$2.24
High today$2.24
Low today
$2.01
Low today$2.01
Open price
$2.05
Open price$2.05
Volume
4.65M
Volume4.65M
52 Week high
$18.71
52 Week high$18.71
52 Week low
$0.6801
52 Week low$0.6801

SPRO Earnings

-$1.01
-$0.67
-$0.34
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.